These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29619511)

  • 41. Magnetic Sphincter Augmentation for Gastroesophageal Reflux at 5 Years: Final Results of a Pilot Study Show Long-Term Acid Reduction and Symptom Improvement.
    Saino G; Bonavina L; Lipham JC; Dunn D; Ganz RA
    J Laparoendosc Adv Surg Tech A; 2015 Oct; 25(10):787-92. PubMed ID: 26437027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lower Esophageal Magnetic Sphincter Augmentation for Persistent Reflux After Roux-en-Y Gastric Bypass.
    Muñoz-Largacha JA; Hess DT; Litle VR; Fernando HC
    Obes Surg; 2016 Feb; 26(2):464-6. PubMed ID: 26667163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical outcome after laparoscopic Nissen fundoplication in patients with GERD and PPI refractory heartburn.
    Schwameis K; Oh D; Green KM; Lin B; Zehetner J; Lipham JC; Hagen JA; DeMeester SR
    Dis Esophagus; 2020 Apr; 33(4):. PubMed ID: 31942976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of Magnetic Sphincter Augmentation Across the Spectrum of GERD Disease Severity.
    Schwameis K; Ayazi S; Zheng P; Grubic AD; Salvitti M; Hoppo T; Jobe BA
    J Am Coll Surg; 2021 Mar; 232(3):288-297. PubMed ID: 33387623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial.
    Bonavina L; DeMeester T; Fockens P; Dunn D; Saino G; Bona D; Lipham J; Bemelman W; Ganz RA
    Ann Surg; 2010 Nov; 252(5):857-62. PubMed ID: 21037442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation.
    Rogers BD; Valdovinos LR; Crowell MD; Bell R; Vela MF; Gyawali CP
    Gut; 2021 Mar; 70(3):450-455. PubMed ID: 32467089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic sphincter augmentation: a viable rescue therapy for symptomatic reflux following bariatric surgery.
    Broderick RC; Smith CD; Cheverie JN; Omelanczuk P; Lee AM; Dominguez-Profeta R; Cubas R; Jacobsen GR; Sandler BJ; Fuchs KH; Horgan S
    Surg Endosc; 2020 Jul; 34(7):3211-3215. PubMed ID: 31485930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy comparison of laparoscopic Nissen, Toupet and Dor fundoplication in the treatment of hiatal hernia complicated with gastroesophageal reflux disease].
    Su F; Zhang C; Ke L; Wang Z; Li Y; Li H; Du Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):1014-1020. PubMed ID: 27680070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Omission of preoperative esophageal manometry does not alter operative approach or postoperative dysphagia following laparoscopic paraesophageal hernia repair.
    Zevin B; Jones EL; Martin Del Campo SE; Perry KA
    Dis Esophagus; 2017 Jul; 30(7):1-6. PubMed ID: 30052900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnetic Sphincter Augmentation and Postoperative Dysphagia: Characterization, Clinical Risk Factors, and Management.
    Ayazi S; Zheng P; Zaidi AH; Chovanec K; Chowdhury N; Salvitti M; Komatsu Y; Omstead AN; Hoppo T; Jobe BA
    J Gastrointest Surg; 2020 Jan; 24(1):39-49. PubMed ID: 31388888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease.
    Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oxenberg D; Perez-Castilla A; Netto MG; Soffer E; Boscardin WJ; Crowell MD
    Surgery; 2015 Mar; 157(3):556-67. PubMed ID: 25726315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medium-term outcomes after magnetic sphincter augmentation vs. fundoplication for reflux disease due to hiatal hernia: a propensity-score matched comparison in 282 patients.
    Ibach MJ; Dahlke PM; Wiegrebe S; Hentschel F; Siemssen B
    Surg Endosc; 2024 Sep; 38(9):5068-5075. PubMed ID: 39014181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loosening the belt on magnetic sphincter augmentation indications: does body mass index matter?
    James TJ; Burke JF; Putnam LR; Pan J; Bildzukewicz NA; Bell R; Lipham JC
    Surg Endosc; 2022 Jul; 36(7):4878-4884. PubMed ID: 34750701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication.
    Bonavina L; Horbach T; Schoppmann SF; DeMarchi J
    Surg Endosc; 2021 Jul; 35(7):3449-3458. PubMed ID: 32676727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Modern Magnetic Implant for Gastroesophageal Reflux Disease.
    Ganz RA
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1326-1337. PubMed ID: 28025156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnetic sphincter augmentation vs subtotal gastrectomy with Roux-en-Y reconstruction for the treatment of postsleeve gastrectomy gastroesophageal reflux disease.
    Jefferies RS; Ward MA; Shabbir R; Farias DA; Ogola GO; Leeds SG
    J Gastrointest Surg; 2024 Oct; 28(10):1682-1686. PubMed ID: 39152086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland.
    Harper S; Kartha M; Mealing S; Borbély YM; Zehetner J
    J Med Econ; 2024; 27(1):805-815. PubMed ID: 38820006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modern GERD treatment: feasibility of minimally invasive esophageal sphincter augmentation.
    Schwameis K; Schwameis M; Zörner B; Lenglinger J; Asari R; Riegler FM; Schoppmann SF
    Anticancer Res; 2014 May; 34(5):2341-8. PubMed ID: 24778041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Introduction into the NHS of magnetic sphincter augmentation: an innovative surgical therapy for reflux - results and challenges.
    Prakash D; Campbell B; Wajed S
    Ann R Coll Surg Engl; 2018 Apr; 100(4):251-256. PubMed ID: 29364013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.